FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

29588002: Brompheniramine maleate (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
49500015 Brompheniramine maleate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
49501016 Parabromdylamine maleate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
760498010 Brompheniramine maleate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
49500015 Brompheniramine maleate en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
49500015 Brompheniramine maleate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
49501016 Parabromdylamine maleate en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
49501016 Parabromdylamine maleate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
760498010 Brompheniramine maleate (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
760498010 Brompheniramine maleate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
34201000188118 bromphéniramine maléate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
795951000172116 maléate de bromphéniramine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
34201000188118 bromphéniramine maléate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
795951000172116 maléate de bromphéniramine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
maléate de bromphéniramine Is a Product containing brompheniramine (medicinal product) false Inferred relationship Existential restriction modifier (core metadata concept)
maléate de bromphéniramine Is a Brompheniramine false Inferred relationship Existential restriction modifier (core metadata concept)
maléate de bromphéniramine Has disposition Histamine receptor antagonist (disposition) true Inferred relationship Existential restriction modifier (core metadata concept)
maléate de bromphéniramine Is a Propylamine derivative antihistamine true Inferred relationship Existential restriction modifier (core metadata concept)
maléate de bromphéniramine Is modification of (attribute) Brompheniramine true Inferred relationship Existential restriction modifier (core metadata concept)

Inbound Relationships Type Active Source Characteristic Refinability Group
Brompheniramine maleate+codeine phosphate+phenylpropanolamine hydrochloride 2mg/5mL 10mg/5mL 12.5mg/5mL syrup The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False maléate de bromphéniramine Inferred relationship Existential restriction modifier (core metadata concept)
Brompheniramine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 2mg/5mL 10mg/5mL 30mg/5mL syrup The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False maléate de bromphéniramine Inferred relationship Existential restriction modifier (core metadata concept)
Brompheniramine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride4mg/5mL 15mg/5mL60mg/5mL syrup (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False maléate de bromphéniramine Inferred relationship Existential restriction modifier (core metadata concept)
Brompheniramine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 4mg/5mL 15mg/5mL 45mg/5mL syrup The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False maléate de bromphéniramine Inferred relationship Existential restriction modifier (core metadata concept)
Brompheniramine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride4mg/5mL 30mg/5mL60mg/5mL syrup (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False maléate de bromphéniramine Inferred relationship Existential restriction modifier (core metadata concept)
Brompheniramine maleate+codeine phosphate+phenylpropanolamine hydrochloride The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False maléate de bromphéniramine Inferred relationship Existential restriction modifier (core metadata concept)
Brompheniramine maleate + dextromethorphan hydrobromide + phenylpropanolamine hydrochloride The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False maléate de bromphéniramine Inferred relationship Existential restriction modifier (core metadata concept)
Brompheniramine maleate + phenylpropanolamine The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False maléate de bromphéniramine Inferred relationship Existential restriction modifier (core metadata concept)
Brompheniramine maleate + pseudoephedrine + acetaminophen The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False maléate de bromphéniramine Inferred relationship Existential restriction modifier (core metadata concept)
Brompheniramine maleate + phenylephrine+ phenylpropanolamine The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False maléate de bromphéniramine Inferred relationship Existential restriction modifier (core metadata concept)
Brompheniramine maleate+dextromethorphan hydrobromide+phenylpropanolamine hydrochloride 2mg/5mL 10mg/5mL 12.5mg/5mL syrup The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False maléate de bromphéniramine Inferred relationship Existential restriction modifier (core metadata concept)
Brompheniramine maleate + dextromethorphan hydrobromid + phenylpropanolamine hydrochl 2mg/10mg/12.5mg liquid (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False maléate de bromphéniramine Inferred relationship Existential restriction modifier (core metadata concept)
Brompheniramine maleate + guaifenesin + hydrocodone bitartrate 2mg/200mg/5mg syrup The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False maléate de bromphéniramine Inferred relationship Existential restriction modifier (core metadata concept)
Brompheniramine maleate+hydrocodone bitartrate+pseudoephedrine hydrochlorid 2mg/1.7mg/30mg The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False maléate de bromphéniramine Inferred relationship Existential restriction modifier (core metadata concept)
Brompheniramine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False maléate de bromphéniramine Inferred relationship Existential restriction modifier (core metadata concept)
Brompheniramine maleate + hydrocodone bitartrate + pseudoephedrine hydrochloride The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False maléate de bromphéniramine Inferred relationship Existential restriction modifier (core metadata concept)
Brompheniramine maleate 2mg/5mL elixir The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False maléate de bromphéniramine Inferred relationship Existential restriction modifier (core metadata concept)
Brompheniramine maleate + pseudoephedrine hydrochloride 16mg/240mg m/r tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False maléate de bromphéniramine Inferred relationship Existential restriction modifier (core metadata concept)
Brompheniramine maleate 10mg/1mL injection 10mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False maléate de bromphéniramine Inferred relationship Existential restriction modifier (core metadata concept)
Product containing brompheniramine maleate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False maléate de bromphéniramine Inferred relationship Existential restriction modifier (core metadata concept)
Brompheniramine maleate 6 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False maléate de bromphéniramine Inferred relationship Existential restriction modifier (core metadata concept)
Brompheniramine maleate 10mg/mL injection solution ampule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False maléate de bromphéniramine Inferred relationship Existential restriction modifier (core metadata concept)
Brompheniramine maleate + pseudoephedrine hydrochlorid 12mg/120mg capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False maléate de bromphéniramine Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely brompheniramine 6 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False maléate de bromphéniramine Inferred relationship Existential restriction modifier (core metadata concept)
Brompheniramine maleate + pseudoephedrine hydrochloride The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False maléate de bromphéniramine Inferred relationship Existential restriction modifier (core metadata concept)
Brompheniramine maleate 6 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False maléate de bromphéniramine Inferred relationship Existential restriction modifier (core metadata concept) 1
Brompheniramine maleate 6 mg oral tablet Has basis of strength substance (attribute) True maléate de bromphéniramine Inferred relationship Existential restriction modifier (core metadata concept) 1
Brompheniramine maleate + pseudoephedrine hydrochloride 16mg/240mg prolonged-release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False maléate de bromphéniramine Inferred relationship Existential restriction modifier (core metadata concept)
Brompheniramine maleate 6 mg oral tablet Has precise active ingredient True maléate de bromphéniramine Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely brompheniramine maleate 400 microgram/1 milliliter conventional release oral solution (clinical drug) Has precise active ingredient True maléate de bromphéniramine Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely brompheniramine maleate 400 microgram/1 milliliter conventional release oral solution (clinical drug) Has basis of strength substance (attribute) True maléate de bromphéniramine Inferred relationship Existential restriction modifier (core metadata concept) 1
Brompheniramine maleate 400 microgram/mL and guaifenesin 40 mg/mL and hydrocodone bitartrate 1 mg/mL oral solution Has basis of strength substance (attribute) True maléate de bromphéniramine Inferred relationship Existential restriction modifier (core metadata concept) 1
Brompheniramine maleate 400 microgram/mL and guaifenesin 40 mg/mL and hydrocodone bitartrate 1 mg/mL oral solution Has precise active ingredient True maléate de bromphéniramine Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely brompheniramine maleate 10 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True maléate de bromphéniramine Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely brompheniramine maleate 10 milligram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance (attribute) True maléate de bromphéniramine Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely brompheniramine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 9 milligram/1 milliliter conventional release oral solution (clinical drug) Has precise active ingredient True maléate de bromphéniramine Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely brompheniramine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 9 milligram/1 milliliter conventional release oral solution (clinical drug) Has basis of strength substance (attribute) True maléate de bromphéniramine Inferred relationship Existential restriction modifier (core metadata concept) 2
Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and pseudoephedrine hydrochloride 6 mg/mL oral solution Has precise active ingredient True maléate de bromphéniramine Inferred relationship Existential restriction modifier (core metadata concept) 2
Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and pseudoephedrine hydrochloride 6 mg/mL oral solution Has basis of strength substance (attribute) True maléate de bromphéniramine Inferred relationship Existential restriction modifier (core metadata concept) 2
Brompheniramine maleate 400 microgram/mL and codeine phosphate 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution Has precise active ingredient True maléate de bromphéniramine Inferred relationship Existential restriction modifier (core metadata concept) 2
Brompheniramine maleate 400 microgram/mL and codeine phosphate 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution Has basis of strength substance (attribute) True maléate de bromphéniramine Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug) Has precise active ingredient True maléate de bromphéniramine Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug) Has basis of strength substance (attribute) True maléate de bromphéniramine Inferred relationship Existential restriction modifier (core metadata concept) 1
Brompheniramine maleate 3 mg and caffeine 30 mg and paracetamol 325 mg oral tablet Has precise active ingredient True maléate de bromphéniramine Inferred relationship Existential restriction modifier (core metadata concept) 2
Brompheniramine maleate 3 mg and caffeine 30 mg and paracetamol 325 mg oral tablet Has basis of strength substance (attribute) True maléate de bromphéniramine Inferred relationship Existential restriction modifier (core metadata concept) 2

Reference Sets

Concept inactivation indicator attribute value reference set (foundation metadata concept)

Back to Start